129 related articles for article (PubMed ID: 38125000)
1. Commentary: 31-Gene Expression Profile Testing in Cutaneous Melanoma and Survival Outcomes in a Population-Based Analysis: A SEER Collaboration.
Prieto PA
J Clin Aesthet Dermatol; 2023 Dec; 16(12 Suppl 1):S9-S11. PubMed ID: 38125000
[No Abstract] [Full Text] [Related]
2. Cutaneous Melanoma of the Lip: A SEER Analysis of Epidemiology and Survival Outcomes With Focus on Surgery and Other Treatment Options.
Viscardi JA; Scampa M; Walz SN; Martineau J; DI Summa PG; Giordano S; Kalbermatten DF; Oranges CM
In Vivo; 2023; 37(3):1164-1172. PubMed ID: 37103103
[TBL] [Abstract][Full Text] [Related]
3. A population-based validation of the American Joint Committee on Cancer melanoma staging system.
Gimotty PA; Botbyl J; Soong SJ; Guerry D
J Clin Oncol; 2005 Nov; 23(31):8065-75. PubMed ID: 16258105
[TBL] [Abstract][Full Text] [Related]
4. Construction and validation of a prognostic nomogram for primary vulvar melanoma: a SEER population-based study.
Zhou H; Zou X; Li H; Chen L; Cheng X
Jpn J Clin Oncol; 2020 Dec; 50(12):1386-1394. PubMed ID: 32776099
[TBL] [Abstract][Full Text] [Related]
5. Development and Validation of a Modified Pathologic Nodal Classification System for Cutaneous Melanoma.
Nguyen AT; Luu M; Nguyen VP; Hamid O; Faries MB; Gharavi NM; Lu DJ; Mallen-St Clair J; Ho AS; Zumsteg ZS
JAMA Surg; 2021 Nov; 156(11):e214298. PubMed ID: 34468697
[TBL] [Abstract][Full Text] [Related]
6. Prognostic role of sentinel lymph node biopsy for patients with cutaneous melanoma: A retrospective study of surveillance, epidemiology, and end-result population-based data.
Chen J; Xu Y; Zhou Y; Wang Y; Zhu H; Shi Y
Oncotarget; 2016 Jul; 7(29):45671-45677. PubMed ID: 27344178
[TBL] [Abstract][Full Text] [Related]
7. Anatomic Region of Cutaneous Melanoma Impacts Survival and Clinical Outcomes: A Population-Based Analysis.
Shannon CM; Mehta NK; Li H; Nguyen SA; Koochakzadeh S; Elston DM; Kaczmar JM; Day TA
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831571
[TBL] [Abstract][Full Text] [Related]
8. Presentation, Management, and Prognosis of Primary Gastrointestinal Melanoma: A Population-Based Study.
Kahl AR; Gao X; Chioreso C; Goffredo P; Hassan I; Charlton ME; Lin C
J Surg Res; 2021 Apr; 260():46-55. PubMed ID: 33316759
[TBL] [Abstract][Full Text] [Related]
9. Impact of aging on host immune response and survival in melanoma: an analysis of 3 patient cohorts.
Weiss SA; Han J; Darvishian F; Tchack J; Han SW; Malecek K; Krogsgaard M; Osman I; Zhong J
J Transl Med; 2016 Oct; 14(1):299. PubMed ID: 27760559
[TBL] [Abstract][Full Text] [Related]
10. Reporting cutaneous melanoma to cancer registries in the United States.
Hall HI; Jamison P; Fulton JP; Clutter G; Roffers S; Parrish P
J Am Acad Dermatol; 2003 Oct; 49(4):624-30. PubMed ID: 14512907
[TBL] [Abstract][Full Text] [Related]
11. Incidence of Cutaneous Melanoma of Eyelid Analysis of the Surveillance, Epidemiology, and End Results Database.
Brunetti P; Margo CE; French DD
Ocul Oncol Pathol; 2021 Mar; 7(1):66-69. PubMed ID: 33796520
[TBL] [Abstract][Full Text] [Related]
12. Malignant Melanoma in African-Americans: A Population-Based Clinical Outcomes Study Involving 1106 African-American Patients from the Surveillance, Epidemiology, and End Result (SEER) Database (1988-2011).
Mahendraraj K; Sidhu K; Lau CSM; McRoy GJ; Chamberlain RS; Smith FO
Medicine (Baltimore); 2017 Apr; 96(15):e6258. PubMed ID: 28403068
[TBL] [Abstract][Full Text] [Related]
13. Clinical correlates and prognostic value of different metastatic sites in patients with malignant melanoma of the skin: a SEER database analysis.
Abdel-Rahman O
J Dermatolog Treat; 2018 Mar; 29(2):176-181. PubMed ID: 28745581
[TBL] [Abstract][Full Text] [Related]
14. Deep-learning-based survival prediction of patients with cutaneous malignant melanoma.
Yu H; Yang W; Wu S; Xi S; Xia X; Zhao Q; Ming WK; Wu L; Hu Y; Deng L; Lyu J
Front Med (Lausanne); 2023; 10():1165865. PubMed ID: 37051218
[TBL] [Abstract][Full Text] [Related]
15. Increased relative proportions of advanced melanoma among veterans: A comparative analysis with the Surveillance, Epidemiology, and End Results registry.
Chang MS; La J; Trepanowski N; Cheng D; Bihn JR; Do N; Brophy M; Fillmore NR; Hartman RI
J Am Acad Dermatol; 2022 Jul; 87(1):72-79. PubMed ID: 35595121
[TBL] [Abstract][Full Text] [Related]
16. Risks for noncutaneous second primary malignancy in cutaneous malignant melanoma survivors: an analysis of data from the Surveillance, Epidemiology, and End Results (SEER) program.
Vakharia PP; Kelm RC; Orrell KA; Patel KR; Singam V; Ali Y; Rastogi S; Yousif R; Rangel SM; West DP; Nardone B
Int J Dermatol; 2020 Apr; 59(4):463-468. PubMed ID: 31971260
[TBL] [Abstract][Full Text] [Related]
17. Survival of cutaneous melanoma based on sex, age, and stage in the United States, 1992-2011.
Enninga EAL; Moser JC; Weaver AL; Markovic SN; Brewer JD; Leontovich AA; Hieken TJ; Shuster L; Kottschade LA; Olariu A; Mansfield AS; Dronca RS
Cancer Med; 2017 Oct; 6(10):2203-2212. PubMed ID: 28879661
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology and survival outcomes of ocular and mucosal melanomas: a population-based analysis.
Bishop KD; Olszewski AJ
Int J Cancer; 2014 Jun; 134(12):2961-71. PubMed ID: 24272143
[TBL] [Abstract][Full Text] [Related]
19. Incidence, Surgical Treatment, and Prognosis of Anorectal Melanoma From 1973 to 2011: A Population-Based SEER Analysis.
Chen H; Cai Y; Liu Y; He J; Hu Y; Xiao Q; Hu W; Ding K
Medicine (Baltimore); 2016 Feb; 95(7):e2770. PubMed ID: 26886623
[TBL] [Abstract][Full Text] [Related]
20. Vulvar/vaginal melanoma: an updated surveillance epidemiology and end results database review, comparison with cutaneous melanoma and significance of racial disparities.
Mert I; Semaan A; Winer I; Morris RT; Ali-Fehmi R
Int J Gynecol Cancer; 2013 Jul; 23(6):1118-25. PubMed ID: 23765206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
